Christopher M. Hoffmann

700 total citations
15 papers, 456 citations indexed

About

Christopher M. Hoffmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Christopher M. Hoffmann has authored 15 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in Christopher M. Hoffmann's work include Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Cells and Metastasis (5 papers). Christopher M. Hoffmann is often cited by papers focused on Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Cells and Metastasis (5 papers). Christopher M. Hoffmann collaborates with scholars based in Germany, China and Spain. Christopher M. Hoffmann's co-authors include Claudia R. Ball, Hanno Glimm, Sebastian M. Dieter, Friederike Herbst, Manfred Schmidt, Wilko Weichert, Moritz Koch, Ulrich Abel, Jürgen Weitz and Christof von Kalle and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Christopher M. Hoffmann

12 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher M. Hoffmann Germany 8 313 228 129 86 45 15 456
Lu-Zhe Pan Canada 5 332 1.1× 245 1.1× 184 1.4× 127 1.5× 44 1.0× 5 562
Anette Heller Germany 10 188 0.6× 152 0.7× 83 0.6× 90 1.0× 33 0.7× 13 365
Jitka Holčáková Czechia 16 237 0.8× 371 1.6× 121 0.9× 34 0.4× 67 1.5× 32 549
Junjie Ye China 10 167 0.5× 207 0.9× 117 0.9× 95 1.1× 38 0.8× 17 385
Trevor G. Levin United States 6 189 0.6× 147 0.6× 74 0.6× 45 0.5× 30 0.7× 15 314
Lisa van Voorthuijsen Netherlands 8 184 0.6× 372 1.6× 81 0.6× 81 0.9× 16 0.4× 8 556
Yalei Zhang China 9 158 0.5× 178 0.8× 61 0.5× 73 0.8× 47 1.0× 14 351
Francesco Bonetto United States 10 205 0.7× 252 1.1× 52 0.4× 44 0.5× 24 0.5× 14 426
Suzanne Camus United Kingdom 10 206 0.7× 370 1.6× 78 0.6× 33 0.4× 18 0.4× 10 470
Dorthe Gylling Crüger Denmark 15 185 0.6× 275 1.2× 96 0.7× 122 1.4× 54 1.2× 23 572

Countries citing papers authored by Christopher M. Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Christopher M. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Hoffmann more than expected).

Fields of papers citing papers by Christopher M. Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Hoffmann. The network helps show where Christopher M. Hoffmann may publish in the future.

Co-authorship network of co-authors of Christopher M. Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Hoffmann. A scholar is included among the top collaborators of Christopher M. Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Hoffmann. Christopher M. Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Brückl, W., Martin Reck, Frank Griesinger, et al.. (2021). Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice. Therapeutic Advances in Medical Oncology. 13. 4277424393–4277424393. 10 indexed citations
2.
Tourneau, C. Le, Valentin Calugaru, Zoltán Takácsi‐Nagy, et al.. (2021). OC-0515 NBTXR3 activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients. Radiotherapy and Oncology. 161. S399–S399.
3.
Metzenmacher, Martin, Kato Kambartel, Jens Panse, et al.. (2021). Real-World Efficacy of Docetaxel Plus Nintedanib After Chemo-Immunotherapy Failure in Advanced Pulmonary Adenocarcinoma. Future Oncology. 17(30). 3965–3976. 7 indexed citations
4.
Brueckl, Wolfgang M., Martin Reck, C. Kortsik, et al.. (2020). Efficacy of afatinib in the clinical practice: Final results of the GIDEON study in EGFR mutated non-small cell lung cancer (NSCLC) in Germany.. Journal of Clinical Oncology. 38(15_suppl). e21636–e21636. 2 indexed citations
5.
Brückl, W., et al.. (2019). P2.01-79 Afatinib in EGFR Mutation-Positive (EGFRm+) NSCLC Harbouring Uncommon Mutations: Experience in ‘Real-World’ Clinical Practice. Journal of Thoracic Oncology. 14(10). S670–S671. 2 indexed citations
6.
Weber, Sarah, Sebastian E. Koschade, Christopher M. Hoffmann, et al.. (2019). The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo. BMC Cancer. 19(1). 1181–1181. 20 indexed citations
7.
Laack, Eckart, Christopher M. Hoffmann, Martin Reck, et al.. (2019). Patients with brain metastases treated with afatinib in clinical practice: Results from the prospective non-interventional study GIDEON. Annals of Oncology. 30. v631–v631. 1 indexed citations
8.
9.
Ball, Claudia R., Felix Oppel, Taronish D. Dubash, et al.. (2017). Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts. EMBO Molecular Medicine. 9(7). 918–932. 27 indexed citations
10.
Dubash, Taronish D., Christopher M. Hoffmann, Felix Oppel, et al.. (2015). Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells. Cancer Letters. 371(2). 326–333. 8 indexed citations
11.
Bach, Patricia, Tobias Abel, Christopher M. Hoffmann, et al.. (2013). Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus. Cancer Research. 73(2). 865–874. 100 indexed citations
12.
Azoitei, Ninel, Christopher M. Hoffmann, Jana M. Ellegast, et al.. (2012). Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33. The Journal of Experimental Medicine. 209(4). 697–711. 53 indexed citations
13.
Dieter, Sebastian M., Claudia R. Ball, Christopher M. Hoffmann, et al.. (2011). Distinct Types of Tumor-Initiating Cells Form Human Colon Cancer Tumors and Metastases. Cell stem cell. 9(4). 357–365. 225 indexed citations
14.
Dieter, Sebastian M., Claudia R. Ball, Christopher M. Hoffmann, et al.. (2010). Abstract 9: Distinct types of human colon cancer initiating cells contribute to primary tumor and metastasis formation. Cancer Research. 70(8_Supplement). 9–9. 1 indexed citations
15.
Shreeve, S. Martin, Dario Palmieri, Kenneth Aldape, et al.. (2008). Correlation of hexokinase-2 expression with overall survival and potential as a therapeutic target in the treatment of breast cancer brain metastases. Journal of Clinical Oncology. 26(15_suppl). 1005–1005.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lu-Zhe Pan Breakdown of academic impact, for papers by Anette Heller Breakdown of academic impact, for papers by Jitka Holčáková Breakdown of academic impact, for papers by Junjie Ye Breakdown of academic impact, for papers by Trevor G. Levin Breakdown of academic impact, for papers by Lisa van Voorthuijsen Breakdown of academic impact, for papers by Yalei Zhang Breakdown of academic impact, for papers by Francesco Bonetto Breakdown of academic impact, for papers by Suzanne Camus Breakdown of academic impact, for papers by Dorthe Gylling Crüger
Rankless by CCL
2026